UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients

Journal of neurology, 2022-02, Vol.269 (2), p.824-835

2022

Volltextzugriff (PDF)

Grey matter atrophy in patients with benign multiple sclerosis

Brain and behavior, 2022-07, Vol.12 (7), p.e2679-n/a

2022

Volltextzugriff (PDF)

Effect of Middle Cerebral Artery Territory Ischemic Stroke on QT Interval

Journal of stroke and cerebrovascular diseases, 2014-04, Vol.23 (4), p.717-723

2014

Volltextzugriff (PDF)

Response to Kurtoglu and Balta

Clinical autonomic research, 2014-04, Vol.24 (2), p.93-93

2014

Volltextzugriff (PDF)

Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis

Multiple sclerosis, 2016-07, Vol.22 (8), p.1080-1085

2016

Volltextzugriff (PDF)

Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio angiogenesis trial (KAT)

Circulation (New York, N.Y.), 2003-06, Vol.107 (21), p.2677-2683

2003

Volltextzugriff (PDF)

Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation

Multiple sclerosis and related disorders, 2020-02, Vol.38, p.101498-101498, Article 101498

2020

Volltextzugriff (PDF)

Fatigue and health-related quality of life depend on the disability status and clinical course in RRMS

Multiple sclerosis and related disorders, 2023-09, Vol.77, p.104861-104861, Article 104861

2023

Volltextzugriff (PDF)

Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis

Multiple sclerosis and related disorders, 2021-11, Vol.56, p.103280-103280, Article 103280

2021

Volltextzugriff (PDF)

Heart rate variability associates with asymptomatic coronary atherosclerosis

Clinical autonomic research, 2014-02, Vol.24 (1), p.31-37

2014

Volltextzugriff (PDF)

Corrigendum to “Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation” [Multiple Sclerosis and Related Disorders 38 (2020) 101498]

Multiple sclerosis and related disorders, 2020-06, Vol.41, p.102107-102107, Article 102107

2020

Volltextzugriff (PDF)

Sequence of cardiovascular autonomic alterations after fingolimod initiation

Annals of noninvasive electrocardiology, 2017-09, Vol.22 (5), p.n/a

2017

Volltextzugriff (PDF)

Effects of Three Months Fingolimod Therapy on Heart Rate

Journal of neuroimmune pharmacology, 2015-12, Vol.10 (4), p.651-654

2015

Volltextzugriff (PDF)

Cardiac repolarization evolves differently during the course of benign and disabling multiple sclerosis

Multiple sclerosis and related disorders, 2018-02, Vol.20, p.205-209

2018

Volltextzugriff (PDF)

Baroreflex sensitivity in asymptomatic coronary atherosclerosis

Clinical physiology and functional imaging, 2013-01, Vol.33 (1), p.70-74

2013

Volltextzugriff (PDF)

The impact of multiple sclerosis onset symptom on cardiac repolarization

Brain and behavior, 2017-07, Vol.7 (7), p.e00742-n/a

2017

Volltextzugriff (PDF)

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

Brain and behavior, 2018-02, Vol.8 (2), p.e00925-n/a

2018

Volltextzugriff (PDF)

Heart Rate Variability Predicts the Magnitude of Heart Rate Decrease after Fingolimod Initiation

Multiple sclerosis and related disorders, 2016-11, Vol.10, p.86-89

2016

Volltextzugriff (PDF)

Myocardial (123) I-metaiodobenzylguanidine washout and heart rate variability in asymptomatic subjects

Annals of noninvasive electrocardiology, 2012-01, Vol.17 (1), p.8

2012

Volltextzugriff (PDF)

Myocardial 123I-metaiodobenzylguanidine Washout and Heart Rate Variability in Asymptomatic Subjects

Annals of noninvasive electrocardiology, 2012-01, Vol.17 (1), p.8-13

2012

Volltextzugriff (PDF)

Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulation

Physiological reports, 2016-09, Vol.4 (17), p.e12870-n/a

2016

Volltextzugriff (PDF)

Myocardial 123 I‐metaiodobenzylguanidine Washout and Heart Rate Variability in Asymptomatic Subjects

Annals of noninvasive electrocardiology, 2012-01, Vol.17 (1), p.8-13

2012

Volltextzugriff (PDF)

Cardiac Adrenergic Activity Is Associated with Left Ventricular Hypertrophy in Genetically Homogeneous Subjects with Hypertrophic Cardiomyopathy

The Journal of nuclear medicine (1978), 2003-04, Vol.44 (4), p.487-493

2003

Volltextzugriff (PDF)

Cardiac Adrenergic Innervation Is Affected in Asymptomatic Subjects with Very Early Stage of Coronary Artery Disease

The Journal of nuclear medicine (1978), 2002-01, Vol.43 (1), p.1-7

2002

Volltextzugriff (PDF)

Cardiac adrenergic denervation in patients with non-Q-wave versus Q-wave myocardial infarction

European journal of nuclear medicine, 2000-07, Vol.27 (7), p.816-821

2000

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDuodecim

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(20)
Male
(18)
Female
(17)
Adult
(14)
Neurosciences & Neurology
(14)
Middle Aged
(13)
Multiple Sclerosis
(12)
Clinical Neurology
(9)
Neurosciences
(9)
Electrocardiography
(8)
Heart Rate
(8)
Heart Rate - Physiology
(7)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(7)
Heart Rate Variability
(6)
Biological And Medical Sciences
(5)
Coronary Artery Disease
(5)
Fingolimod
(5)
Heart Rate - Drug Effects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients

Grey matter atrophy in patients with benign multiple sclerosis

Effect of Middle Cerebral Artery Territory Ischemic Stroke on QT Interval

Response to Kurtoglu and Balta

Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis

Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio angiogenesis trial (KAT)

Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation

Fatigue and health-related quality of life depend on the disability status and clinical course in RRMS

Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis

Heart rate variability associates with asymptomatic coronary atherosclerosis

Corrigendum to “Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation” [Multiple Sclerosis and Related Disorders 38 (2020) 101498]

Sequence of cardiovascular autonomic alterations after fingolimod initiation

Effects of Three Months Fingolimod Therapy on Heart Rate

Cardiac repolarization evolves differently during the course of benign and disabling multiple sclerosis

Baroreflex sensitivity in asymptomatic coronary atherosclerosis

The impact of multiple sclerosis onset symptom on cardiac repolarization

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

Heart Rate Variability Predicts the Magnitude of Heart Rate Decrease after Fingolimod Initiation

Myocardial (123) I-metaiodobenzylguanidine washout and heart rate variability in asymptomatic subjects

Myocardial 123I-metaiodobenzylguanidine Washout and Heart Rate Variability in Asymptomatic Subjects

Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulation

Myocardial 123 I‐metaiodobenzylguanidine Washout and Heart Rate Variability in Asymptomatic Subjects

Cardiac Adrenergic Activity Is Associated with Left Ventricular Hypertrophy in Genetically Homogeneous Subjects with Hypertrophic Cardiomyopathy

Cardiac Adrenergic Innervation Is Affected in Asymptomatic Subjects with Very Early Stage of Coronary Artery Disease

Cardiac adrenergic denervation in patients with non-Q-wave versus Q-wave myocardial infarction

Aktive Filter

Suchergebnisse filtern